Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Eldor

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Diabetes Care|March 29, 2005
Lipids and glucose in type 2 diabetes: what about the beta-cell and the mitochondria?: response to Boden and LaaksoRoy Eldor, Itamar Raz
Diabetes/Metabolism Research and Reviews|January 3, 2013
Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagoguesRoy Eldor, Itamar Raz
Diabetes Care|October 31, 2009
American Diabetes Association indications for statins in diabetes: is there evidence?Roy Eldor, Itamar Raz
The New England Journal of Medicine|May 26, 2007
New treatments for diabetesItamar Raz, Roy Eldor
Diabetes/Metabolism Research and Reviews|December 17, 2011
Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarmsItamar Raz, Roy Eldor
The Review of Diabetic Studies : RDS|June 27, 2009
The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight GainRoy Eldor, Itamar Raz
Trends in Biotechnology|March 1, 2005
Immune modulation for prevention of type 1 diabetes mellitusItamar Raz, Roy Eldor, Yaakov Naparstek
Acute Cardiac Care|December 13, 2006
Intensive insulin therapy in the intensive cardiac care unitTal Hasin, Roy Eldor, Haim Hammerman
Diabetes/Metabolism Research and Reviews|March 10, 2009
Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial resultsRoy Eldor, Sameer Kassem, Itamar Raz
International Reviews of Immunology|December 2, 2005
Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitusRoy Eldor, Irun R Cohen, Itamar Raz
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Diabetes Care|March 29, 2005
Lipids and glucose in type 2 diabetes: what about the beta-cell and the mitochondria?: response to Boden and LaaksoRoy Eldor, Itamar Raz
Diabetes/Metabolism Research and Reviews|January 3, 2013
Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagoguesRoy Eldor, Itamar Raz
Diabetes Care|October 31, 2009
American Diabetes Association indications for statins in diabetes: is there evidence?Roy Eldor, Itamar Raz
The New England Journal of Medicine|May 26, 2007
New treatments for diabetesItamar Raz, Roy Eldor
Diabetes/Metabolism Research and Reviews|December 17, 2011
Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarmsItamar Raz, Roy Eldor
The Review of Diabetic Studies : RDS|June 27, 2009
The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight GainRoy Eldor, Itamar Raz
Trends in Biotechnology|March 1, 2005
Immune modulation for prevention of type 1 diabetes mellitusItamar Raz, Roy Eldor, Yaakov Naparstek
Acute Cardiac Care|December 13, 2006
Intensive insulin therapy in the intensive cardiac care unitTal Hasin, Roy Eldor, Haim Hammerman
Diabetes/Metabolism Research and Reviews|March 10, 2009
Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial resultsRoy Eldor, Sameer Kassem, Itamar Raz
International Reviews of Immunology|December 2, 2005
Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitusRoy Eldor, Irun R Cohen, Itamar Raz
Pageof 7